Kymera Therapeutics, Inc. (KYMR) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.74B | +78.2% |
| 2024 | $978.03M | +69.9% |
| 2023 | $575.76M | -4.5% |
| 2022 | $603.13M | -0.5% |
| 2021 | $605.90M | +24.4% |
| 2020 | $487.18M | +317.5% |
| 2019 | $116.70M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.74B | +78.2% |
| 2024 | $978.03M | +69.9% |
| 2023 | $575.76M | -4.5% |
| 2022 | $603.13M | -0.5% |
| 2021 | $605.90M | +24.4% |
| 2020 | $487.18M | +317.5% |
| 2019 | $116.70M | — |